Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance
Business Wire•05/11/2026•16:05 ET
0
Key Highlights
- ➤Adjusted EBITDA $33.9 million, up 24% year-over-year
- ➤Net income $19.1 million, versus $9.6 million year-over-year
- ➤FY 2026 adjusted EBITDA guidance raised to $136 million-$138 million
- ➤FY 2026 revenue guidance raised to $1.44 billion-$1.46 billion
- ➤Residents served reached approximately 218,000, up 7% year-over-year
Expert Statements
Fred Burke, President and Chief Executive Officer of Guardian Pharmacy Services, Inc.
“We are very pleased with our third-quarter performance, highlighted by strong resident and prescription growth. Absent the price reductions from the IRA, revenues would have been up high single digits compared to the third quarter of 2025, mostly driven by organic growth”
Fred Burke, President and Chief Executive Officer of Guardian Pharmacy Services, Inc.
“Our margin improvement demonstrates the scalability of Guardian's operating model, as well as the progress we are making in driving profitability and leverage across our growing resident base. This performance, together with our positive outlook for the remainder of the year, supports our decision to raise full-year guidance.”
Fred Burke, President and Chief Executive Officer of Guardian Pharmacy Services, Inc.
“With favorable industry fundamentals, a substantial runway for growth, and a liquid balance sheet, we believe Guardian is well positioned to generate durable growth and attractive long-term returns for shareholders.”
Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2026. The Company also raised its full-year guidance.
Get started
Create a free account to read the full story.